Gilead Sciences' (GILD) Antiviral Drug Remdesivir Flops in First trial - FT
Go back to Gilead Sciences' (GILD) Antiviral Drug Remdesivir Flops in First trial - FT| Gilead Sciences (NASDAQ: GILD) | Delayed: 151.00 -0.22 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $151.22 | 52 Week High | $108.63 | |||
| Open | $149.23 | 52 Week Low | $71.39 | |||
| Day High | $151.19 | P/E | 83.43 | |||
| Day Low | $149.23 | EPS | $1.81 | |||
| Volume | 6,181,813 | |||||
| S&P DEP RECEIPTS (NYSE: SPY) | Delayed: 770.19 -2.98 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $773.17 | 52 Week High | $219.60 | |||
| Open | $772.01 | 52 Week Low | $181.02 | |||
| Day High | $772.87 | P/E | N/A | |||
| Day Low | $769.00 | EPS | $0.00 | |||
| Volume | 34,054,816 | |||||
